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Cholesterol-rich membranes or detergent-resistant
membranes (DRMs) have recently been isolated from
bovine rod outer segments and were shown to contain
several signaling proteins such as, for example, transdu-
cin and its effector, cGMP-phosphodiesterase PDE6.
Here we report the presence of rhodopsin kinase and
recoverin in DRMs that were isolated in either light or
dark conditions at high and low Ca2 concentrations.
Inhibition of rhodopsin kinase activity by recoverin was
more effective in DRMs than in the initial rod outer
segment membranes. Furthermore, the Ca2 sensitivity
of rhodopsin kinase inhibition in DRMs was shifted to
lower free Ca2 concentration in comparison with the
initial rod outer segment membranes (IC50  0.76 M in
DRMs and 1.91 M in rod outer segments). We relate this
effect to the high cholesterol content of DRMs because
manipulating the cholesterol content of rod outer seg-
ment membranes by methyl--cyclodextrin yielded a
similar shift of the Ca2-dependent dose-response curve
of rhodopsin kinase inhibition. Furthermore, a high
cholesterol content in the membranes also increased the
ratio of the membrane-bound form of recoverin to its
cytoplasmic free form. These data suggest that the Ca2-
dependent feedback loop that involves recoverin is spa-
tially heterogeneous in the rod cell.
Phototransduction in retinal rod and cone cells is started
with the absorption of light by the photopigment rhodopsin, a
seven-transmembrane helix receptor. Activated rhodopsin
(metarhodopsin II) couples to a heterotrimeric G-protein,
transducin, and thereby activates the visual enzymatic cascade
that leads to the amplified hydrolysis of cGMP by cGMP-phos-
phodiesterase (1, 2). Cyclic nucleotide-gated cation channels in
the photoreceptor plasma membrane are opened by cGMP in
the dark and closed after hydrolysis of cGMP in light. Closure
of channels causes hyperpolarization of the cell plasma mem-
brane, which ultimately leads to a reduction of transmitter
release at the synapse (3). A decrease in cytoplasmic cGMP is
accompanied by a decrease in free cytoplasmic Ca2, which is
sensed by Ca2 sensor proteins that regulate their target pro-
teins in a Ca2-dependent fashion. For example, calmodulin
influences the ligand sensitivity of the cation channels (4), and
guanylate cyclase-activating proteins activate two membrane-
bound guanylate cyclases at low Ca2 concentrations (5–9).
Phosphorylation and deactivation of rhodopsin are catalyzed by
rhodopsin kinase, which is under Ca2-dependent control by
the Ca2-binding protein recoverin (10–13). These Ca2-de-
pendent feedback loops are necessary to restore the dark state
of the cell and to adjust the light sensitivity of the photorecep-
tor cell to different intensities of ambient illumination
(1–3, 14).
A photoreceptor cell consists of distinct cellular compart-
ments (outer segment, inner segment, and synaptic terminal),
and these compartments differ in their Ca2 homeostasis and
protein content (1, 16). Protein translocation between compart-
ments along the longitudinal axis was observed for some key
signaling proteins such as transducin, arrestin, and protein
phosphatase 2A (17–20). In addition, a spatial heterogeneity of the
cholesterol content in the stacked disk membranes of rod outer
segments (ROSs)1 was observed along the axis of the outer seg-
ment. Newly formed disks at the basal part of the outer segment
contain a high amount of cholesterol of 30% of the total lipid
content. The percentage of cholesterol decreases during aging of the
disk membranes and reaches a mere 5% at the tip end of ROSs
(21–23). Cholesterol can inhibit cGMP-phosphodiesterase activity
(23) and interferes with formation of photoexcited rhodopsin by
influencing membrane acyl chain packing (24). Taken together,
these results point to a spatial heterogeneity of visual transduction
in ROSs. In fact, single photon responses recorded from the tip of a
toad ROS are smaller in amplitude and slower than responses
recorded from the base. Background light reduces flash sensitivity
at the tip more than at the base (25). Although this spatial heter-
ogeneity of the light response has been known for more than 20
years, it has not been understood at the cellular and molecular
levels.
Recent reports have stimulated discussion about the spatial
heterogeneity of the rod light response. Detergent-resistant
membranes (DRMs) or lipid rafts that contain a high choles-
terol/phospholipid ratio have recently been isolated from bo-
vine ROSs (26–30). A light-dependent translocation into DRMs
has been demonstrated for transducin; its effector, cGMP-phos-
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phodiesterase; the shorter splice variant of arrestin p44; and
the RGS9-G5L complex (26, 27, 29, 30). ROM-1, a disk mem-
brane protein, which probably functions as an adaptor protein,
was copurified with DRM fractions but only showed a modest
light-dependent distribution between the DRMs and the deter-
gent-soluble fractions (28). Caveolin and membrane guanylate
cyclase (probably retina-specific ROS-GC1) reside in DRMs but
do not show any light-dependent translocation (26). Rod func-
tion is under dynamic control of Ca2-mediated feedback loops,
and Ca2 regulates the longitudinal transport of transducin
(17), but it is not known whether any signaling proteins differ-
ent from those mentioned above associate with DRMs or
whether Ca2 is involved in this association. In the present
study, we investigated this issue as applied to the Ca2 sensor
recoverin and its target, rhodopsin kinase, to answer questions
regarding whether these proteins associate with DRMs and
which functional consequences follow from such an interaction.
EXPERIMENTAL PROCEDURES
Isolation of DRMs from Bovine Rod Outer Segments—ROSs from
bovine retinae were purified according to a previously published proce-
dure (15). DRMs or lipid rafts were isolated from bovine ROSs by the
following procedure of Nair et al. (26), with some modifications. Briefly,
ROSs were adjusted to 10 mg/ml rhodopsin in buffer A (100 mM KCl,
2 mM MgCl2, 1 mM dithiothreitol, and 10 mM Hepes, pH 7.4). For one
gradient, 500 l of ROSs in buffer A were mixed with 2 ml of buffer B
(12.5 mM Tris, pH 7.4, 1.25 mM CaCl2, 1.25 mM MgCl2, and 0.63% (v/v)
Triton X-100) and incubated for 5 min on ice or at 4 °C. This solution
was mixed with 2.5 ml of 80% (w/v) sucrose in an ultracentrifuge tube.
The mixture was then carefully overlaid with 4.6 ml of 30% sucrose and
2.3 ml of 5% sucrose. Samples were centrifuged at 24,000 rpm in SW-41
rotor (Beckman) at 4 °C overnight. The whole procedure was performed
in either dim red light (dark) or under daylight conditions. In some
preparations, CaCl2 was replaced by 1 mM EGTA. When gradients were
run for comparison, exactly the same amount of ROS was loaded on the
gradient. In addition, we increased the Triton X-100 concentration that
was used for solubilization to 1% and 2% (v/v). Alternatively, we iso-
lated DRMs according to the procedure of Boesze-Battaglia et al. (28).
After centrifugation, we collected 24 fractions (500 l) of the gradient
from bottom to the top using a glass capillary tube and a perstaltic
pump.
Determination of Rhodopsin and Cholesterol—Rhodopsin concentra-
tion in purified ROSs or in fractions obtained after DRM isolation and
fractionation was determined spectrophotometrically at 498 nm using a
molar extinction coefficient of 40,000 M1  cm1. The amount of
rhodopsin (in mg) in each of the 25 fractions was summed up and set as
100%. Numbering starts with fractions at the top. Cholesterol was
determined by a diagnostic kit according to the manufacturer’s protocol
(Sigma and Rolf Greiner Biochemica, Flacht, Germany). The principle
of the assay is as follows: cholesterol is oxidized to cholest-4-en-3-one
and H2O2 by cholesterol oxidase. H2O2 was allowed to react with hy-
droxybenzoic acid and 4-aminoantipyrin in the presence of peroxidase
to yield chinomeimin, a dye that can be measured spectrophotometri-
cally at 530 nm.
Adjusting Cholesterol in ROSMembranes—The cholesterol exchange
between methyl--cyclodextrin and ROSs was performed as described
previously (24). Briefly, urea-washed ROS membranes (30 M rhodop-
sin) in 10 mM Tris-HCl (pH 7.5), 60 mM NaCl, and 30 mM KCl were
incubated with methyl--cyclodextrin in the presence or absence of 2
mM cholesterol. Mixtures were incubated in the dark at 25 °C for 2 h.
Afterward, ROS membranes were pelleted by centrifugation for 30 min
at 29,000  g. The pellet was resuspended in 10 mM Tris-HCl (pH 7.5)
containing 0.1 mM EDTA and 5% (w/v) Ficoll. Aliquots of this suspen-
sion were layered on top of 31% sucrose in 10 mM Tris-HCl (pH 7.5) and
overlaid with 10 mM Tris-HCl (pH 7.5). Tubes were spun for 3 h at
21,000 rpm in a Beckman SW-28 rotor. Layers with ROS membranes
were collected with a syringe and washed three times with 10 mM
Tris-HCl (pH 7.5). The cholesterol content of each sample was meas-
ured by using the Amplex red kit (Molecular Probes), according to the
manufacturer’s directions. Cholesterol content is expressed as a per-
centage (w/w) of phospholipids. Phospholipid content was determined
as follows. Lipids were extracted from ROS membrane suspensions by
chloroform-methanol (2:1, v/v) and by a second extraction step using
chloroform-methanol-HCl (200:100:1, v/v). Further processing of the
lipid-containing fractions was as described previously (31). Phospholip-
ids in the lipid extract from ROS membranes were analyzed by normal
phase HPLC (silica gel cartridge, 0.46  20 cm; Vydac) essentially as
described previously (32–34), using the UV absorption between 200 and
210 nm for detection. Known standards of phospholipids were injected
into the HPLC to quantitate the unknown phospholipid content of
ROS membranes.
Purification of Recoverin and Phosphorylation of Rhodopsin—Myris-
toylated recoverin was heterologously expressed in Escherichia coli and
purified from a cell extract as described previously (35, 36). Phospho-
rylation of rhodopsin was assayed as described in Ref. 35 at 25 °C in the
reaction mixture (50 l) containing 20 mM Tris-HCl (pH 7.5), 150 mM
NaCl, 3 mM MgCl2, 200 M [-
32P]ATP (1–3  105 cpm/nmol), about 1
unit of rhodopsin kinase, ROS membranes or DRMs (see figure leg-
ends), and myristoylated recoverin (see figure legends). Free calcium
concentration ([Ca2]free) was adjusted as described previously (35) and
varied as indicated in the corresponding figures. Immediately after
illumination of the mixture (100% bleaching of rhodopsin), ATP was
added to start the reaction, which was stopped 20 min later or by the
addition of the 2 SDS-PAGE sample buffer. After SDS-PAGE of the
samples, zones of rhodopsin were cut out, and 32P incorporation was
estimated by Cherenkov counting.
Surface Plasmon Resonance Spectroscopy—Hydrophobic L1 sensor
chips (Biacore, Stockholm, Sweden) were used to immobilize lipid mix-
tures of phosphatidylcholine, phosphatidylethanolamine, and choles-
terol. Recoverin was applied in the mobile phase in running buffer (10
mM Hepes, pH 7.5, 150 mM KCl, 20 mM MgCl2, and 0.2 mM CaCl2) at a
flow rate at 5 l/min. Details of surface plasmon resonance experiments
and analysis have been described elsewhere (35–37).
Other Methods—Equilibrium centrifugation assay for the binding of
recoverin to liposomes, SDS-PAGE, and Western blotting have been
described previously (8, 35). Antibodies for Western blotting were from
the following sources and used at indicated dilutions: polyclonal anti-
recoverin (Ref. 38; 1:10,000) and polyclonal anti-ROS-GC1 (Ref. 39,
1:1,000). Polyclonal anti-rhodopsin kinase (1:1,000), polyclonal anti-
transducin  (1:1,000), and polyclonal anti-caveolin (1:200) were from
Santa Cruz Biotechnology (Santa Cruz, CA).
RESULTS
We isolated a Triton X-100-insoluble membrane fraction
from bovine ROS using a sucrose density gradient centrifuga-
tion. Samples were fractionated after the centrifugation step,
and the cholesterol content along the gradient was determined
by a colorimetric assay. Almost all cholesterol was found in a
peak that centered around fraction 6 (Fig. 1A). This distribu-
tion pattern of cholesterol was not changed significantly when
we performed the whole isolation procedure either in the pres-
ence of Ca2 or EGTA, after illumination, or in the dark (Fig.
1A). The main cholesterol peak coincided with the position of a
nearly transparent yellow band at the boundary between 5%
and 30% sucrose. This band (boundary fraction) has previously
been identified as DRMs or lipid rafts from ROS (26–28).
The rhodopsin distribution along the sucrose gradient was
analyzed by absorption measurements. The main portion of
rhodopsin was solubilized by Triton X-100 and found in frac-
tions 12–23 (89%); a smaller portion of 10% was found at the
5% and 30% sucrose boundary (fractions 5–9) and comigrated
with the cholesterol peak (Fig. 1B). Up to 23% rhodopsin was
found in DRMs. Fractions 1 and 2 contained only 1% rhodopsin.
The presence of rhodopsin in DRMs is consistent with previous
observations (27). A critical parameter for solubilization of
rhodopsin was the rhodopsin/Triton X-100 ratio. For example,
when we treated ROSs containing 4.5–4.6 mg/ml rhodopsin
with 0.5% or 1% (v/v) Triton X-100, the amount of rhodopsin
and other proteins in DRMs was similar at both detergent
concentrations. However, decreasing the start amount of rho-
dopsin to 1.7 mg/ml in either 1% or 2% Triton X-100 led to
almost complete solubilization of rhodopsin (1% rhodopsin in
DRMs). The cholesterol peak at the boundary between 5% and
30% sucrose also decreased by increasing Triton X-100:
whereas at 0.5% Triton X-100, nearly 100% of total cholesterol
comigrated with the boundary fraction, it was 37% and 12% of
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total cholesterol at 1% Triton X-100 and 2% Triton X-100,
respectively. These results showed that rhodopsin was com-
pletely solubilized under conditions that left a significant
amount of cholesterol associated with the boundary fraction.
We further tested by Western blotting whether other ROS
membrane proteins known to be associated with DRMs (26–30)
are present in our DRM preparation. Guanylate cyclase ROS-
GC1 and cGMP-phosphodiesterase were present in DRM and
non-DRM fractions; transducin showed a clear light-dependent
translocation into the DRM fraction (data not shown). Caveo-
lin, a marker protein for lipid rafts, was found almost exclu-
sively in the DRM fraction (Fig. 2A). Interestingly, less caveolin
was detected in DRMs after illumination (Fig. 2A). Although
the intensity of caveolin staining was variable, we observed
this light-dependent distribution of caveolin in two independ-
ent fractionation studies. It is known that caveolin associates
in a cholesterol-dependent manner with transducin (29) and
that transducin undergoes a light-dependent translocation
from the outer segment to the inner segment (17, 18). A com-
bination of these two effects could explain our observation.
In summary, we conclude from these results that our DRM
preparation from bovine ROS contains the same signaling pro-
teins as reported by other investigators. It is therefore suitable
for our further investigations.
When we probed all fractions of the gradient by antibodies
against recoverin and rhodopsin kinase, both proteins were
detected in the DRM and non-DRM fraction. A comparison of
the gradients run in the presence of Ca2 or EGTA under dark
or light conditions showed in all cases the presence of recoverin
and rhodopsin kinase in the DRM fraction and a clear segre-
gation between DRM and non-DRM fractions (Fig. 2A). How-
ever, the relative amount of each protein in DRMs was influ-
enced by Ca/EGTA and/or by illumination. For example,
FIG. 1. Distribution of cholesterol (A) and rhodopsin (B) along
a sucrose gradient. Fractions of0.5 ml were collected and measured
for content of cholesterol (absorbance at 530 nm in A) and rhodopsin (B).
Numbering of fractions goes from top (fraction 1) to bottom (fraction 23).
Fractions 4–9 contain DRMs. Preparations were performed with or
without Ca2 in the dark or after illumination as indicated in A.
Rhodopsin concentration was determined in the dark-kept fractions
(gradient run in the presence of Ca2) and expressed in mg/ml. Gray
bars in B indicate the total amount (mg) of rhodopsin in each fraction.
FIG. 2. Distribution of recoverin and rhodopsin kinase in
DRMs and non-DRMs obtained under different conditions. A, 42
l of each of the fractions (fractions 3–23) shown in Fig. 1 was loaded on
a SDS-polyacrylamide gel and analyzed. Proteins (recoverin, rhodopsin
kinase, and caveolin-1) were detected by Western blotting. Conditions
under which the sucrose gradients were run are indicated. B, distribu-
tion of recoverin and rhodopsin kinase in DRMs of different gradient
runs under the indicated conditions. The starting concentration of rho-
dopsin was 1.84 mg/ml instead of 1.66 mg/ml, and therefore the rho-
dopsin:Triton X-100 ratio was slightly higher than that in A.
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recoverin in the DRM fraction decreased after illumination in
the presence of EGTA (Fig. 2A). Distribution of rhodopsin ki-
nase resembled that of recoverin, but the presence of rhodopsin
kinase became most prominent after illumination in the pres-
ence of Ca2. The relative amount of recoverin and rhodopsin
kinase in DRMs varied among different preparations, as can be
seen best in a comparison of Fig. 2A with Fig. 2B. The effect of
switching from Ca2 to EGTA during DRM isolation is more
pronounced in Fig. 2B because the presence of EGTA reduced
the amount of recoverin and rhodopsin kinase in the
DRM fraction.
We next asked whether the inhibition of rhodopsin kinase
activity by recoverin in DRMs differs from the inhibition in
ROS membranes. In titration experiments, we varied either
the recoverin concentration at saturating [Ca2] or [Ca2]free at
a constant recoverin concentration. At saturating [Ca2], inhi-
bition of rhodopsin kinase occurred at slightly lower recoverin
concentrations (Fig. 3A). However,whenwe compared theCa2-
dependent phosphorylation of rhodopsin in ROS membranes
with that in isolated DRMs, we observed a significant shift of
the IC50 to lower free Ca
2 concentrations (from 1.91 M in
ROS membranes to 0.76 M in DRMs) (Fig. 3B). Thus, recov-
erin was more effective as an inhibitor of rhodopsin kinase in
DRMs than it was in ROS membranes. Overall activity of
rhodopsin kinase without interference by recoverin was iden-
tical in ROS membranes and DRMs for nearly 20 min of incu-
bation. Longer incubation times showed 20% lower kinase
activity in ROS membranes.
Because cholesterol is a main constituent of DRMs, we tested
how cholesterol influenced the membrane association and in-
hibitory properties of recoverin. The cholesterol content of na-
tive bovine ROS membranes was manipulated by treatment
with methyl--cyclodextrin, and the binding of recoverin was
measured by a centrifugation equilibrium assay. Native ROS
membranes contained, on average, 14% cholesterol. Decreasing
the cholesterol content to 4.1% also decreased the amount of
bound recoverin, whereas an increase of cholesterol to 29.6%
increased the amount of bound recoverin at least 2-fold (Fig. 4).
These results showed that binding of recoverin to membranes
strongly depended on the cholesterol content of the mem-
branes. Control incubations with nonmyristoylated recoverin
and arrestin showed no dependence on either Ca2/EGTA or
the percentage of cholesterol (data not shown).
We also tested the recoverin-dependent inhibition of rhodop-
sin kinase activity when cholesterol in ROS membranes was
varied (Fig. 5A). The kinase activity was determined by meas-
uring phosphorylation of rhodopsin. Inhibition of rhodopsin
kinase was half-maximal at 6.6 M recoverin in untreated ROS
(14% cholesterol) and shifted to a higher value when choles-
terol was lowered (IC50  10.4 M at 4.1% cholesterol) or to a
lower value when cholesterol was higher (IC50  4.5 M at
29.6% cholesterol).
FIG. 3. Rhodopsin kinase activity in isolated DRMs was com-
pared with the activity in ROS membranes. A, Pelleted DRMs (E)
or ROS membranes (●) were incubated with rhodopsin kinase at 200
M CaCl2 and increasing concentrations of recoverin. Inhibition was
half-maximal at 5.3 M recoverin with ROS membranes and 4.9 M
recoverin with DRMs. B, Pelleted DRMs (E) or ROS membranes (●)
were incubated with 20 M recoverin and rhodopsin kinase at different
[Ca2]free. IC50 values for Ca
2 were 1.91 M (ROS membranes) and
0.76 M (DRMs). DRMs were prepared in the absence of Ca2 after
illumination; they contained only a small amount of endogenous rho-
dopsin kinase and recoverin.
FIG. 4. Binding of recoverin to native ROS membranes with
different percentages of cholesterol. Cholesterol in native ROS
membranes was adjusted by treatment with methyl--cyclodextrin (●,
29.6%; E, 14%; , 4.1% cholesterol). Recoverin (30 M) was incubated
with membranes at different rhodopsin concentrations and analyzed by
equlibrium centrifugation assay. Inset, corresponding SDS-PAGE anal-
ysis (Coomassie Blue staining) of membrane-bound recoverin at differ-
ent percentages of cholesterol (right) and the indicated rhodopsin con-
centration (bottom).
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Inhibition of rhodopsin kinase by recoverin depends also on
[Ca2]free (11–13). We tested whether a change in the choles-
terol content of native ROS membranes has any influence on
the Ca2-dependent activity of rhodopsin kinase. Increasing
the cholesterol content from 4.1% to 29.4% shifted the dose-
response curve to lower [Ca2]free, and the IC50 changed from
4.31 to 0.82 M [Ca2]free (Fig. 5B). At intermediate levels of
cholesterol, the IC50 was 2.43 M. These results were consistent
with our observation that inhibition of rhodopsin kinase by
recoverin is more efficient and occurs at lower [Ca2]free in
DRMs than in ROSmembranes. The results also implicate that
the shift in the dose-response curve shown in Fig. 3 cannot be
attributed to detergent treatment because no detergents were
needed to adjust different cholesterol levels. Furthermore, the
binding experiments shown in Fig. 4 indicate that recoverin is
bound more strongly to membranes when higher cholesterol
levels are adjusted.
We also tested the influence of cholesterol on the membrane
association of recoverin at saturating [Ca2] using phospho-
lipid vesicles containing phosphatidylethanolamine (PE) and
phosphatidylcholine (PC) at a ratio of 50:50 without cholesterol
or with increasing amounts of cholesterol (5–50%) by keeping
the PC:PE ratio constant. Binding of recoverin to the vesicles
was tested by an equilibrium centrifugation assay. Vesicles
without cholesterol showed less than half of recoverin binding
compared with vesicles containing increasing amounts of cho-
lesterol in addition to PE and PC (Fig. 6).
In our previous work, we used immobilized lipids on sensor
chips to explore membrane association of recoverin by surface
plasmon resonance spectroscopy (35–37). Here we applied this
method to test the influence of cholesterol upon recoverin bind-
ing to immobilized lipids. A phospholipid mixture of PE and PC
(50:50) was immobilized on a hydrophobic sensor chip, and
association of myristoylated recoverin was recorded in the pres-
ence of saturating [Ca2]. The resonance signal exhibited a
rapid association phase and a biphasic dissociation phase that
is typical for wild-type myristoylated recoverin (Fig. 7A; com-
pare with Fig. 5 in Ref. 35). When the immobilized lipid mix-
ture contained cholesterol (Fig. 7A, top trace), the maximal
amplitude of the binding signal increased about 2-fold. Inter-
estingly, the slower phase of the biphasic dissociation signal
was more prominent in the presence of cholesterol. Variation of
the recoverin concentration revealed the same result: in the
presence of cholesterol, the maximal amplitude of the binding
signal was at least twice as high as that in the absence of
cholesterol (Fig. 7B). Control recordings with protein G in the
presence and absence of cholesterol showed no significant dif-
ference of sensorgram amplitudes, which were similar to the
amplitude we reported previously for protein G binding to an
immobilized lipid mix (see Fig. 3B in Ref. 35).
In summary, our results suggest that the high cholesterol
content of DRMs facilitates binding of recoverin to membranes
and enforces inhibition of rhodopsin kinase by two means: it
decreases the amount of recoverin at which kinase activity is
half-maximal, and it shifts the dose-response curve to lower
[Ca2]free.
DISCUSSION
The light-driven transport of signaling proteins between
photoreceptor cell compartments has received growing atten-
tion in recent years (17–20). In addition to these longitudinal
transport processes, lateral translocation of proteins within
disk membranes and into DRMs or lipid rafts has come into
focus (26–30). Here we show for the first time that the Ca2
sensor recoverin and its target, rhodopsin kinase, are present
in DRMs of bovine rod cells and undergo a Ca2-dependent
translocation within ROS membranes. A decrease of Ca2, by
FIG. 5. Rhodopsin kinase activity at different cholesterol lev-
els. A, Rhodopsin kinase activity was determined as a function of
recoverin concentration. Different cholesterol levels in membranes were
adjusted by treatment with methyl--cyclodextrin (●, 29.6%; E, 14%; ,
4.1%). Half-maximal inhibition was at 4.5, 6.6, and 10.4 M recoverin at
29.6%, 14%, and 4.1% cholesterol, respectively. B, Rhodopsin kinase
activity was measured as a function of [Ca2]free in the presence of 20
M recoverin. Cholesterol adjustment and symbols are the same as
those described in A. IC50 values of [Ca
2]free were 0.82 (29.6% choles-
terol), 2.43 (14% cholesterol), and 4.31 M (4.1% cholesterol).
FIG. 6. Binding of recoverin to liposomes as a function of cho-
lesterol. Liposomes with varying cholesterol content were incubated
with 20 M recoverin in the presence of 200 M CaCl2. After centrifu-
gation, the amount of bound recoverin was determined.
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complexing with EGTA, minimized the presence of recoverin
and rhodopsin kinase in DRMs. This finding reflects the Ca2-
myristoyl switch of recoverin (40) and also the Ca2-dependent
interaction of recoverin with rhodopsin kinase (10–13). Recov-
erin has a myristoyl group covalently attached at its N termi-
nus. In the presence of Ca2, this group is exposed and facili-
tates membrane binding. Decreasing Ca2 leads to a
conformational change that enables the myristoyl group to be
buried inside a hydrophobic pocket of the protein. As a conse-
quence, recoverin is released from the membrane (40). Our
data show that the driving force of recoverin to associate with
DRMs was the high cholesterol content that is a characteristic
property of DRMs preparations.
According to our present data, cholesterol has a profound
effect on the efficiency with which recoverin controls rhodopsin
kinase activity. In cholesterol-containing DRMs, inhibition of
rhodopsin kinase became more efficient at lower [Ca2]free.
There has been a dispute in the literature (13, 41–43) about the
physiological role of rhodopsin kinase inhibition by recoverin,
but recent work on recoverin knockout mice has shown that the
physiological role of recoverin is consistent with an effective
prolongation of the catalytic activity of photoexcited rhodopsin
(i.e. inhibition of rhodopsin kinase; Ref. 44). A main argument
against such a role under in vivo conditions is the experimen-
tally observed high IC50 for [Ca
2]free, which is about 1 order of
magnitude higher than the cytoplasmic [Ca2]free in a dark-
adapted rod cell (41). However, it has been argued that the IC50
value can be shifted into the physiologically relevant range
when the data on rhodopsin kinase inhibition are extrapolated
to the membrane-rich in vivo conditions of the rod cell (13, 42).
Our results may provide an experimentally based solution to
this problem because we show that high cholesterol content in
membranes can shift the IC50 to lower [Ca
2]free: 0.76 M in
native DRMs and 0.82 M in ROS membranes with high cho-
lesterol content (29.6%). These values are in the physiological
range of free Ca2 in rod cells. Our data also show that the
ratio of membrane-bound recoverin to cytoplasmic free recov-
erin is increased at high cholesterol content (Fig. 4), which
causes more effective inhibitory action of recoverin.
In accordance with the well-described cholesterol gradient in
rods (5% at the tip and 30% at the base; see “Introduction”), one
could conclude that control of rhodopsin kinase activity by
recoverin is spatially heterogenous and thus would contribute
to the shape of the photoresponse at the base of a ROS differ-
ently than at the tip. It is known that photoresponses from rods
depend on the longitudinal position of photon absorption (25).
Responses from the base of a ROS are faster and have a larger
peak amplitude; in the presence of background light flash,
sensitivity is lower at the tip than at the base of ROS. If
inhibition of rhodopsin kinase is stronger at the base than at
the tip, the photoresponse of a dark-adapted cell would become
larger and last longer. However, this is opposite to what was
observed after single photon absorption (25). However, flash
sensitivity in the presence of background light is higher at the
base of the ROS, which would be consistent with a stronger
inhibition of rhodopsin kinase at the base.
The above prediction is rather simplified and made under the
assumption that other proteins have similar properties in
DRMs and outside DRMs. However, T is suggested to have a
reduced coupling to rhodopsin in DRMs (26). Furthermore,
cholesterol inhibits cGMP-phosphodiesterase activity and
metarhodopsin II formation (23, 24); cholesterol inhibits the
latter by influencing the acyl chain packing of surrounding
lipids. Finally, the splice variant of arrestin p44 that is found in
DRMs after illumination (26) can be bound to nonphosphory-
lated metarhodopsin II with a rather low off-rate (0.07 s1) and
would thereby prevent transducin activation (45). Together,
these findings suggest that phototransduction in DRMs is
less efficient.
A significant amount of rhodopsin (10–23% of total) was also
found in DRMs, but increasing the Triton X-100 concentration
led to the complete solubilization of rhodopsin, whereas a sig-
nificant amount of cholesterol still comigrated with the 5%/30%
boundary. These results could indicate that rhodopsin is not
associated with DRMs or simply that Triton X-100 has a higher
potency to solubilize rhodopsin than to solubilize cholesterol.
We cannot distinguish between these possibilities. Further-
more, our data do not allow us to draw any conclusions about
the preexistence of rafts before treatment with detergent. How-
ever, we emphasize that the existence or nonexistence of rafts
is irrelevant to our observation that cholesterol has a signifi-
cant impact on membrane association of recoverin and on in-
hibition of rhodopsin kinase. Thus, taking the cholesterol gra-
dient in ROSs into account, we assume that rhodopsin in a
cholesterol rich-environment is more restricted in diffusion and
that phototransduction in DRMs works less efficiently (see
above for a discussion of the literature). As a consequence, the
base of the ROS would contain a significant amount of signal-
ing proteins in a “caged-like state” unable to transmit the light
FIG. 7. Surface plasmon resonance analysis of recoverin bind-
ing to immobilized lipids. A, Lipids containing PE:PC at a ratio of
50:50 or PE:PC:cholesterol at a ratio of 25:25:50 were immobilized on a
hydrophobic L1 sensor chip. Recoverin (5 M) was injected into the
buffer flow over the surface (black bar). Sensorgrams were run in the
presence of 200 M CaCl2. B. Maximal amplitudes of recorded sensor-
grams were plotted as a function of the injected recoverin concentration.
Two different lipid layers were compared as described in A.
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signal. This reduction in signaling molecules is reminiscent of
transgenic mice that harbor a hemizygous knockout of rhodop-
sin resulting in a reduction of rhodopsin by 50% (46). Photo-
responses from these transgenic mice have accelerated rising
and recovery phases due to less protein crowding and facili-
tated diffusion. In fact, they qualitatively resemble the single
photon responses from ROS base with faster rising and recov-
ery phases.
In summary, inhibition of rhodopsin kinase by recoverin (i.e.
less efficient phosphorylation of rhodopsin) seems to be more
pronounced at the base than at the tip of ROS, if we consider
the effects of different cholesterol contents. Interpretation of
photoresponses published in the literature leads us to suggest
that these signaling events are more important under constant
background light and not under the single photon regime of
dark-adapted rods.
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